These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 835377

  • 1. Restricted lignocaine prophylaxis in acute myocardial infarction.
    Löfmark R, Orinius E.
    Acta Med Scand; 1977 Jan; 201(1-2):89-91. PubMed ID: 835377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG, Wyman RM, Cannom DS, Criley JM.
    Am J Cardiol; 2004 Sep 01; 94(5):545-51. PubMed ID: 15342281
    [Abstract] [Full Text] [Related]

  • 4. Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
    Antman EM, Berlin JA.
    Circulation; 1992 Sep 01; 86(3):764-73. PubMed ID: 1516188
    [Abstract] [Full Text] [Related]

  • 5. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials.
    DeSilva RA, Hennekens CH, Lown B, Casscells W.
    Lancet; 1981 Oct 17; 2(8251):855-8. PubMed ID: 6116964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ventricular fibrillation complicating acute myocardial infarction: reasons against the routine use of lidocaine.
    Carruth JE, Silverman ME.
    Am Heart J; 1982 Sep 17; 104(3):545-50. PubMed ID: 7113894
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.
    Kertes P, Hunt D.
    Br Heart J; 1984 Sep 17; 52(3):241-7. PubMed ID: 6380549
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KS, Armstrong PW, Granger CB, APEX AMI Investigators.
    JAMA; 2009 May 06; 301(17):1779-89. PubMed ID: 19417195
    [Abstract] [Full Text] [Related]

  • 16. [Prevalence of late potentials in acute myocardial infarction and its relation to ventricular arrhythmias in early period of acute myocardial infarction (AMI)].
    Gang E, Peter T, Ma H.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Dec 06; 18(6):331-2, 381. PubMed ID: 2093549
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT, MADIT-II Research Group.
    Heart Rhythm; 2007 Nov 06; 4(11):1395-402. PubMed ID: 17954398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.